Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -265.54M | -455.26M | -804.90M | 210.69M | -195.69M |
| Total Depreciation and Amortization | 29.16M | 29.74M | 31.46M | 29.77M | 30.94M |
| Total Amortization of Deferred Charges | 1.39M | 1.24M | 465.00K | 660.00K | 752.00K |
| Total Other Non-Cash Items | 555.42M | 363.52M | 695.12M | -352.39M | 304.29M |
| Change in Net Operating Assets | -306.62M | 66.47M | 79.06M | 133.45M | -118.59M |
| Cash from Operations | 13.81M | 5.71M | 1.20M | 22.17M | 21.70M |
| Capital Expenditure | -28.76M | -31.17M | -3.14M | -31.89M | -11.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 14.00M |
| Other Investing Activities | -40.00K | -66.00K | -49.00K | -76.00K | 7.00K |
| Cash from Investing | -28.80M | -31.24M | -3.18M | -31.97M | 2.36M |
| Total Debt Issued | 610.16M | 447.61M | -- | -- | -- |
| Total Debt Repaid | -13.64M | -264.40M | -15.56M | -17.26M | -18.30M |
| Issuance of Common Stock | 2.97M | 1.55M | 367.00K | 55.01M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.32M | -2.53M | 0.00 | 16.61M | -- |
| Cash from Financing | 598.17M | 182.22M | -15.19M | 54.36M | -18.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 583.18M | 156.70M | -17.17M | 44.57M | 5.77M |
